CENTESSA PHARMACEUTICALS (260) — Financial Flexibility Index
CENTESSA PHARMACEUTICALS (260) has a Financial Flexibility Index of -0.47x as of March 2026. Free cash flow of €-72.22 Million (operating CF €-72.22 Million minus capex €0.00) represents 0% of total liabilities (€154.41 Million). Check financial resilience of CENTESSA PHARMACEUTICALS to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CENTESSA PHARMACEUTICALS Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for CENTESSA PHARMACEUTICALS across 4 annual periods. Explore CENTESSA PHARMACEUTICALS (260) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Financial Flexibility Index for CENTESSA PHARMACEUTICALS (2022–2025)
Year-by-year free cash flow to debt coverage for CENTESSA PHARMACEUTICALS. For the full cash flow conversion analysis, see cash flow conversion of CENTESSA PHARMACEUTICALS.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.20x | €-193.45 Million | €-193.82 Million | €160.63 Million | ▼ -48.6% |
| 2024 | -0.81x | €-142.02 Million | €-142.06 Million | €175.25 Million | ▲ +37.3% |
| 2023 | -1.29x | €-160.17 Million | €-160.34 Million | €124.00 Million | ▲ +30.0% |
| 2022 | -1.84x | €-199.41 Million | €-200.55 Million | €108.14 Million | — |